IKZF1 Gene Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL (NCT06220487) | Nanfang Hospital, Southern Medical University | 2024-02-01 |
Track IKZF1 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.